Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives
Left ventricular hypertrophy (LVH) is a strong predictor of adverse cardiovascular outcomes. It is the result of complex mechanisms that include not only an increase in protein synthesis and cell size but also proliferating cardiac progenitor cells and the influx of bone marrow-derived cells develop...
Saved in:
| Main Authors: | Maria E. Marketou, Fragiskos Parthenakis, Panos E. Vardas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/5720758 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ECG DIAGNOSTICS OF LEFT VENTRICULAR HYPERTROPHY
by: E. I. Yakovenko
Published: (2009-10-01) -
Determinants of left atrial reservoir strain and diagnostic potential for cardiac amyloidosis in pathological left ventricular hypertrophy
by: Katsuji Inoue, et al.
Published: (2025-03-01) -
LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON CHRONIC HAEMODIALYSIS
by: A. G. Strokov, et al.
Published: (2010-06-01) -
Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01) -
The detection of left ventricular hypertrophy and diastolic dysfunction
by: G.R. Norton
Published: (2012-04-01)